Study reveals small doses of antibiotics can boost anti-ageing compounds in gut bacteria

It has been found that a tiny dose of antibiotic can prompt gut bacteria to produce anti-ageing compounds. (Picture Credit: Pexels)

• Tiny doses of cephaloridine prompt gut bacteria to make anti-ageing compounds
• Mice given the antibiotic showed improved metabolic health markers
• Cephaloridine works in the gut, avoiding the bloodstream and reducing side effects.

Did our AI summary help?

Researchers at the Howard Hughes Medical Institute have uncovered a surprising way to encourage gut bacteria to produce compounds linked to longer, healthier lives, using a very small dose of an old antibiotic:

Are you unknowingly carrying anti-ageing factories in your gut? Scientists have found that a tiny dose of an antibiotic can prompt gut bacteria to produce compounds linked to longer, healthier lives, without the drug ever entering the bloodstream.

The study, led by Meng Wang at HHMI’s Janelia Research Campus, suggests that future anti-ageing therapies may work not by acting directly on human cells, but by nudging the trillions of microbes living in the gut to do the work instead.

Also read: Doctor says these 3 medicines can save a heart attack patient

Wang’s team has long been interested in how certain molecules influence ageing. In earlier work, they showed that colanic acid, a substance naturally made by gut bacteria, can extend lifespan in simple organisms such as roundworms and fruit flies. The challenge was figuring out how to boost production of this compound in a practical, controllable way.

Their solution was unexpected. When gut bacteria were exposed to very low doses of the antibiotic cephaloridine, they began producing far higher levels of colanic acid. Roundworms given the antibiotic lived significantly longer, directly linking the microbial response to increased lifespan.

The researchers then tested the approach in mice. Once again, low doses of cephaloridine switched on bacterial genes responsible for making colanic acid. While the mice didn’t live longer within the study period, they did show healthier metabolic markers associated with ageing. Male mice had higher levels of “good” cholesterol and lower levels of “bad” cholesterol, while female mice showed reduced insulin levels, both signs of improved metabolic health.

One of the most striking aspects of the finding is its safety profile. When taken orally, cephaloridine stays in the gut and does not enter the bloodstream. That means it can influence the microbiome without exposing the rest of the body to the drug, avoiding the toxic side effects that often derail long-term treatments.

Rather than killing bacteria, the antibiotic acts more like a signal, coaxing microbes to change their behaviour in ways that benefit the host.

Also read: Rare medical condition leaves Archana Puran Singh’s hand permanently affected, know all about it

According to the researchers, this points to a new class of medicines: drugs designed to guide the microbiome rather than override human biology. If the approach translates to humans, it could reshape how scientists think about ageing, shifting the focus from fighting decline in our own cells to partnering with the organisms that live inside us.

Disclaimer: This article, including health and fitness advice, only provides generic information. Don’t treat it as a substitute for qualified medical opinion. Always consult a specialist for specific health diagnosis.